跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE
Authorized
STANDARD
VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE
baxter corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
30386521edd505bc
Company
baxter corporation
Type
Standard
Approval Details
Approval Id
30386521edd505bc
Drug Approval Canada Name
VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE
Product Name
VANCOMYCIN INJECTION USP IN 0.9% SODIUM CHLORIDE
Status
Marketed
Status Date
2021-01-11
Original Market Date
2021-01-11
Din
02487071
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:12.28.16
Atc Original
J01XA01 VANCOMYCIN
Atc Name
j 01 xa 01
Aig Number
0131315010
Company Name
baxter corporation
Company Address
7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2
Active Ingredients
VANCOMYCIN (VANCOMYCIN HYDROCHLORIDE)
1000 MG / 200 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
30386521edd505bc
Type
Standard
Back to Health Canada Approvals